Medicines Management for Nurses at a Glance is the perfect companion for study and revision for pre-registration nursing and healthcare students. Combining superb full colour illustrations with accessible and informative text, it provides an easy-to-read and supportive guide to the key pharmacological knowledge nursing students and registered nurses need to know.

Table of Contents

• List of Tables
• List of Illustrations
• Preface
• Part 1: Introduction to pharmacology and medicines management
• Chapter 1: Why is managing medicines important in nursing?
• Medicines management and nursing
• Defining medicines management
• Chapter 2: Keeping up to date with medicines management
• Continuing professional development
• Post-registration educational practice
• Chapter 3: What is a medicine?
• How are medicines developed and monitored?
• Chapter 4: Medicines nomenclature: what's in a name?
• Endings
• Chapter 5: Numeracy and medicines management
• Symbols
• Illustrative biological unit standards for medicinal products
• Chapter 6: Clinical pharmacokinetics I
• Absorption
• Distribution
• Chapter 7: Clinical pharmacokinetics II
• Metabolism
• Excretion
• Chapter 8: Routes of administration I
• Oral
• Intravenous
• Intramuscular
• Subcutaneous
• Chapter 9: Routes of administration II
• Inhaled
• Topical
• Transdermal
• Sublingual
• Rectal
• Chapter 10: Pharmacodynamics I
• What is pharmacodynamics?
• Why do chemicals have such varied but specific effects on the body?
• Receptors
• Second messenger systems
• Ion channels
• Chapter 11: Pharmacodynamics II
• Agonists and antagonists
• Receptor specificity
• Enzymes
• Part 2: Managing medicines
• Chapter 12: Dyspepsia
• Dyspepsia
• Antacids
• Histamine (H2) antagonists
• Proton pump inhibitors (PPIs)
• Chapter 13: Acute diarrhoea and constipation
• Acute diarrhoea
• Constipation
• Chapter 14: Chronic bowel disease
• Medications
• Aminosalicylates
• Corticosteroids
• Immunoregulating agents
• Chapter 15: Nausea and vomiting
• Medications
• Metoclopramide
• Antihistamines
• 5-HT3 receptor antagonists
• Chapter 16: Anti-anginals
• Indications
• Nitrates
• Calcium channel blockers
• Chapter 17: Anti-arrhythmics
• Digoxin
• Amiodarone
• Other anti-arrhythmic drugs
• Chapter 18: Heart failure
• Angiotensin converting enzyme (ACE) inhibitors
• Angiotensin-II receptor antagonists
• Other drugs used in heart failure
• Chapter 19: Hypertension
• Drugs used to treat hypertension
• Beta-blockers
• Calcium channel blockers
• Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBS)
• Diuretics
• Other drugs used in hypertension
• Chapter 20: Diuretics
• Pharmacodynamics
• Chapter 21: Respiratory conditions I
• Bronchodilators
• Adrenoceptor agonists
• Antimuscarinic bronchodilators
• Theophylline and aminophylline
• Inhaled corticosteroids
• Leukotriene receptor antagonists
• Chapter 22: Respiratory conditions II
• Decongestants
• Mucolytics
• Antihistamines
• Oxygen
• Chapter 23: Opioid analgesics
• Opioid analgesics
• Commonly used opioid analgesics
• Chapter 24: Anxiolytics and hypnotics
• Benzodiazepines
• Buspirone
• Antidepressants and beta-blockers
• Hypnotics – the ‘Z’ drugs (Zaleplon, Zopiclone and Zolpidem)
• Chapter 25: Antipsychotics
• First-and second-generation antipsychotics
• Chapter 26: Depression
• SSRIs
• Tricyclic and related antidepressants
• Other antidepressants
• Chapter 27: Epilepsy
• Anti-epileptic medication
• Valproate
• Carbamazepine
• General advice
• Chapter 28: Alcohol: detoxification
• Medication that aids in the detoxification process
• Thiamine and B vitamins
• Chapter 29: Alcohol: maintaining abstinence
• Acamprosate
• Disulfiram
• Naltrexone
• Chapter 30: Smoking cessation
• Pharmacodynamics
• Pharmacokinetics
• Chapter 31: Fighting infection
• Bacteria
• Viruses
• Fungi
• Other organisms
• Chapter 32: Antibiotics
• Penicillins
• Cephalosporins
• Other beta-lactam antibiotics
• Beta-lactamases and inhibitors
• Tetracyclines
• Macrolides
• Aminoglycosides
• Metronidazole
• Chapter 33: Diabetes: insulin
• Insulins
• Chapter 34: Diabetes: antiglycaemics
• Biguanides
• Sulfonylureas
• ‘Other’ antidiabetics
• Incretin mimetics
• DPP-4 inhibitors
• Pioglitazone (Actos®)
• Chapter 35: Thyroid conditions
• Hypothyroidism
• Antithyroid drugs
• Chapter 36: Oral contraception
• Hormonal contraception
• Medications
• Chapter 37: Anticoagulants
• Anticoagulants and the clotting cascade
• Chapter 38: Antiplatelet drugs
• Aspirin
• Clopidogrel (Plavix®)
• Dipyridamole
• Other antiplatelets and anticoagulants
• Chapter 39: Musculoskeletal disorders
• Gout
• Allopurinol
• Colchicine
• Chapter 40: Non-steroidal anti-inflammatory drugs and non-opioid analgesics
• Non-steroidal anti-inflammatory drugs
• Details of common NSAIDs
• Non-opioid analgesics
• Chapter 41: Topical agents and emollients
• Fingertip units
• Emollients
• Chapter 42: Topical steroids
• Topical steroids combined with antimicrobial agents
• Treatments for psoriasis
• Part 3: Safe and effective medicines management
• Chapter 43: Medicines management in pregnancy and breastfeeding
• General principles to using medicines in pregnancy
• General approaches to using medicines during breastfeeding
• Chapter 44: Medicines management in children
• Key medicines management issues for children
• Chapter 45: Medicines management in elderly people
• National Service Frameworks
• Key medicines management issues for elderly patients
• Ageing
• Adherence
• Chapter 46: Medicines management in people with hepatic and renal impairment
• Managing medicines in hepatic impairment
• Managing medicines in renal impairment
• Examples of when drug and renal function are considered
• Chapter 47: Drug interactions
• Why are drug interactions important?
• Classification of drug interactions
• Underlying factors
• Chapter 48: Adverse drug reactions
• Why are adverse drug reactions important?
• Classification of adverse drug reactions
• The features of Type A reactions
• The features of Type B reactions
• Predisposing factors
• Chapter 49: Pharmacovigilance
• What is pharmacovigilance? Why is it important?
• What methods are used to monitor the safety of medicines on the market?
• Possible actions to be taken
• Chapter 50: Classification of medicines
• Classification of medicines in the UK
• Controlled drugs